Health
Could SARS-CoV-2 antibody tests before first vaccine dose help increase coverage and protection? – News-Medical.Net
A new study by scientists in the UK raises the very useful hypothesis that natural infection may help spread the vaccine thinner without loss of efficacy.
The end of the ongoing coronavirus disease 2019 (COVID-19) pandemic may be in sight, with several countries having rolled out vaccination programs against the causative pathogen: severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). These campaigns aim to induce population immunity rapidly.
A new study by scientists in the UK raises the very useful hypothesis that natural infection may help spread the vaccine thinner without loss of efficacy.
However, as new variants continue to emerge,…
-
Noosa News18 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News17 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
General15 hours agoDairy farmers devastated by floods across parts of New South Wales
-
Noosa News24 hours agoBrisbane news live: Federal fund for council’s cyclone clean-up dries up